Andlauer Healthcare Group Inc. (TSE:AND – Get Free Report)’s share price reached a new 52-week high on Monday . The stock traded as high as C$46.35 and last traded at C$46.35, with a volume of 1237 shares changing hands. The stock had previously closed at C$46.20.
Analysts Set New Price Targets
AND has been the topic of a number of research reports. TD Securities increased their price objective on shares of Andlauer Healthcare Group from C$53.00 to C$54.00 and gave the company a “buy” rating in a research note on Thursday, November 7th. Scotiabank raised their price target on Andlauer Healthcare Group from C$43.00 to C$44.00 in a research report on Thursday, November 7th. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, Andlauer Healthcare Group presently has a consensus rating of “Moderate Buy” and an average price target of C$48.57.
Read Our Latest Stock Analysis on Andlauer Healthcare Group
Andlauer Healthcare Group Trading Up 0.3 %
Andlauer Healthcare Group Company Profile
Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.
Featured Articles
- Five stocks we like better than Andlauer Healthcare Group
- Find and Profitably Trade Stocks at 52-Week Lows
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- 3 Warren Buffett Stocks to Buy Now
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- Learn Technical Analysis Skills to Master the Stock Market
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.